Docket #: S13-149
Neurexin-1alpha knockout mouse model of autism and schizophrenia
Mouse model used to replicate a gene mutation that has been repeatedly observed in autism and schizophrenia patients.
This invention is jointly owned with UT Southerwestern. For licensing information please contact: TechnologyDevelopment@utsouthwestern.edu
Applications
- Can potentially be used for screening for drugs against neuropsychiatric disorders, for validating drug candidates, or for exploring pathogenetic mechanisms involved in neuropsychiatric disorders
Advantages
- Animal models of schizophrenia and autism are notoriously difficult to generate, and this model replicates not only the genetic nature of these conditions, but also mimics some of the symptoms observed in the conditions.
Publications
- PNAS, October 20, 2009, Vol. 106, No. 42 17908-18003
Similar Technologies
-
Monoclonal antibodies against rat NKp30 (rNKp30) S04-250Monoclonal antibodies against rat NKp30 (rNKp30)
-
Passive Miniature Wireless Pressure Sensor for Bio-monitoring S13-130Passive Miniature Wireless Pressure Sensor for Bio-monitoring
-
Ultrasound-induced convection for drug delivery and controlled perfusion of therapeutics via glymphatic and lymphatic flows S18-056Ultrasound-induced convection for drug delivery and controlled perfusion of therapeutics via glymphatic and lymphatic flows